Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Survival outcome and treatment response of patients with young-onset locally advanced rectal cancer (YO-LARC) receiving total neoadjuvant therapy (TNT).
Authors
Edward McKenna
Medical College of Wisconsin, Milwaukee, WI
Edward McKenna , Carolyn Oxencis , Marie Parish , Daniel Eastwood , James Miller , Aditya V. Shreenivas , Mandana Kamgar , Ben George , William A. Hall , Beth Erickson , Kirk A. Ludwig , Aniko Szabo , James P. Thomas , Sakti Chakrabarti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.044
Abstract #
44
Poster Bd #
C1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.
First Author: Janice Zhao
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Survival outcomes in patients with resectable gastric cancer treated with total neoadjuvant therapy.
First Author: Yun Song